Skip to main content
Top
Published in: Reactions Weekly 1/2021

01-11-2021 | Metastasis | Case report

Vandetanib

Secondary adrenal insufficiency and hypogonadotropic hypogonadism: case report

Published in: Reactions Weekly | Issue 1/2021

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Garcia-Moreno RM, et al. An unusual case of hypopituitarism as an adverse effect of vandetanib and remission of breast metastases in a patient with medullary thyroid cancer. Oncology Research and Treatment 44: 568-572, No. 10, Oct 2021. Available from: URL: http://doi.org/10.1159/000518673 [Summarised from an abstract] Garcia-Moreno RM, et al. An unusual case of hypopituitarism as an adverse effect of vandetanib and remission of breast metastases in a patient with medullary thyroid cancer. Oncology Research and Treatment 44: 568-572, No. 10, Oct 2021. Available from: URL: http://​doi.​org/​10.​1159/​000518673 [Summarised from an abstract]
Metadata
Title
Vandetanib
Secondary adrenal insufficiency and hypogonadotropic hypogonadism: case report
Publication date
01-11-2021
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-05462-6

Other articles of this Issue 1/2021

Reactions Weekly 1/2021 Go to the issue

Case report

TJ-68

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Carboplatin